Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12

International Journal of Cancer

Volumn 136, Issue 1, 2015, Pages 44-54

  Wobus, Manja ^a   List, Catrin ^a   Dittrich, Tobias ^a   Dhawan, Abhishek ^a   Duryagina, Regina ^a   Arabanian, Laleh S ^a   Kast, Karin ^a   Wimberger, Pauline ^a   Stiehler, Maik ^a   Hofbauer, Lorenz C ^b   Jakob, Franz ^c   Ehninger, Gerhard ^a   Anastassiadis, Konstantinos ^b   Bornhäuser, Martin ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

breast carcinoma; CXCL12; hematopoiesis; mesenchymal stromal cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; MICRORNA; MICRORNA 23A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CULTURE MEDIUM; CXCL12 PROTEIN, HUMAN; MIRN23 MICRORNA, HUMAN; TGFB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP1;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STROMAL CELL; BONE MARROW STROMA CELL; BREAST CARCINOMA; CARCINOMA CELL LINE; CELL FUNCTION; CELL MIGRATION; CHEMOATTRACTIVE ACTIVITY; COCULTURE; COLONY FORMING UNIT GM; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; MDA MB231 CELL LINE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; BREAST TUMOR; CASE CONTROL STUDY; CHEMOTAXIS; CULTURE MEDIUM; FEMALE; GENE EXPRESSION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TUMOR EMBOLISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHEMOKINE CXCL12; CHEMOTAXIS; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIESIS; HUMANS; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; MICRORNAS; NEOPLASTIC CELLS, CIRCULATING; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84919362198     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28960     Document Type: Article

References (34)

1. Coleman RE,. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12: 6243s-9s.
2. Kaplan RN, Riba RD, Zacharoulis S, et al., VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-7.
3. Taichman RS,. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 2005; 105: 2631-9.
4. Calvi LM, Adams GB, Weibrecht KW, et al., Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841-6.
5. Kiel MJ, Yilmaz OH, Iwashita T, et al., SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121: 1109-21.
6. Kiel MJ, Morrison SJ,. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008; 8: 290-301.
7. Siclari VA, Guise TA, Chirgwin JM,. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 2006; 25: 621-33.
8. Shiozawa Y, Havens AM, Jung Y, et al., Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem 2008; 105: 370-80.
9. Shiozawa Y, Taichman RS,. Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche. Exp Hematol 2012; 40: 685-94.
10. Mendez-Ferrer S, Lucas D, Battista M, et al., Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008; 452: 442-7.
11. Chabanon A, Desterke C, Rodenburger E, et al., A cross-talk between stromal cell-derived factor-1 and transforming growth factor-beta controls the quiescence/cycling switch of CD34(+) progenitors through FoxO3 and mammalian target of rapamycin. Stem Cells 2008; 26: 3150-61.
12. Pillai MM, Yang X, Balakrishnan I, et al., MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One 2010; 5: e14304.
13. Corcoran KE, Trzaska KA, Fernandes H, et al., Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One 2008; 3: e2563.
14. Shiozawa Y, Pienta KJ, Taichman RS,. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res 2011; 17: 5553-8.
15. Boker W, Yin Z, Drosse I, et al., Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med 2008; 12: 1347-59.
16. Oswald J, Boxberger S, Jorgensen B, et al., Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004; 22: 377-84.
17. Lam BS, Adams GB,. Hematopoietic stem cell lodgment in the adult bone marrow stem cell niche. Int J Lab Hematol 2010; 32: 551-8.
18. Malek A, Nunez LE, Magistri M, et al., Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer. PLoS One 2012; 7: e35130.
19. Arabanian LS, Fierro FA, Stolzel F, et al., miRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells. Haematologica Mar 14. [Epub ahead of print].
20. Aiuti A, Webb IJ, Bleul C, et al., The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111-20.
21. Peled A, Petit I, Kollet O, et al., Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283: 845-8.
22. Taichman RS, Cooper C, Keller ET, et al., Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62: 1832-7.
23. Greenbaum A, Hsu YM, Day RB, et al., CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 2013; 495: 227-30.
24. Mendez-Ferrer S, Battista M, Frenette PS,. Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization. Ann N Y Acad Sci 2010; 1192: 139-44.
25. Hanyu R, Hayata T, Nagao M, et al., Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH. J Cell Biochem 2011; 112: 433-8.
26. Generali D, Berruti A, Tampellini M, et al., The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. Bone 2007; 40: 182-8.
27. Shiozawa Y, Pedersen EA, Havens AM, et al., Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest 2011; 121: 1298-312.
28. Dar A, Schajnovitz A, Lapid K, et al., Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia 2011; 25: 1286-96.
29. Garcia-Moruja C, Alonso-Lobo JM, Rueda P, et al., Functional characterization of SDF-1 proximal promoter. J Mol Biol 2005; 348: 43-62.
30. Mendez-Ferrer S, Lucas D, Battista M, et al., Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008; 452: 442-7.
31. Rana S, Malinowska K, Zoller M,. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013; 15: 281-95.
32. Wright N, de Lera TL, Garcia-Moruja C, et al., Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood 2003; 102: 1978-84.
33. Rosenblatt M,. A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to bone. Trans Am Clin Climatol Assoc 2012; 123: 135-50.
34. Yin X, Wolford CC, Chang YS, et al., ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci 2010; 123: 3558-65.